Table 3.
Stimulation and type of T-cell response evaluation | Cytokine produced | Responders over total N (%) | ||
T2 19 (100) | T3 19 (100) | P value* | ||
Spike-specific CD4+ T cells | Any Th1 | 2 (10.5) | 5 (26.31) | 0.248 |
IFN-γ | 2 (10.5) | 5 (26.31) | 0.248 | |
TNF-α | 2 (10.5) | 0 (0) | 0.479 | |
IL-2 | 0 (0) | 0 (0) | n/a | |
Spike-specific CD8+ T cells | Any Th1 | 2 (10.5) | 2 (10.5) | n/a |
IFN-γ | 1 (5.2) | 2 (10.5) | >0.9999 | |
TNF-α | 1 (5.2) | 0 (0) | >0.9999 | |
IL-2 | 0 (0) | 0 (0) | n/a | |
CD4+ T cells response to SEB | Any Th1 | 17 (89.5) | 19 (100) | 0.479 |
IFN-γ | 16 (84.2) | 19 (100) | 0.248 | |
TNF-α | 17 (89.5) | 19 (100) | 0.479 | |
IL-2 | 10 (60.1) | 5 (26.3) | 0.182 | |
CD8+ T cells response to SEB | Any Th1 | 19 (100) | 19 (100) | n/a |
IFN-γ | 16 (84.2) | 19 (100) | 0.248 | |
TNF-α | 11 (57.9) | 18 (94.7) | 0.045 | |
IL-2 | 11 (57.9) | 3 (15.8) | 0.026 |
In bold are indicated the significant values.
*McNemar’s test.
N, Number; n/a, not available; PwMS, Patients with Multiple Sclerosis; SEB, staphylococcal enterotoxin B.